Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
PNK
Unprofitable
Unprofitable
Relative Strenght
Volume Buzz
5018%
Earning Acce
No
Dist 52w H.
100%Quote Panel
Key Metrics
Fundamentals
Relative Strength
ATRX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.21
N/A
NA
vs NA
Q1.22
N/A
-2.20
vs -1.60
Q2.22
N/A
-0.20
vs -1.60
Q3.22
N/A
-0.57
vs -6.40
Q4.22
N/A
0.7
vs NA
Q1.23
N/A
-0.02
vs -2.20
Q2.23
N/A
-0.01
vs -0.20
Q3.23
N/A
-0.83
vs -0.57
Q4.23
+197%
2.09
vs 0.7
Q1.24
+7982%
1.58
vs -0.02
Sales Growth
YoY
Current
Estimates
Q3.21
NA
NA vs NA
Q4.21
NA
NA vs NA
Q1.22
NA
NA vs NA
Q2.22
NA
NA vs NA
Q3.22
NA
NA vs NA
Q4.22
NA
NA vs NA
Q1.23
NA
NA vs NA
Q2.23
NA
NA vs NA
Q3.23
NA
NA vs NA
Q1.24
NA
878.9K vs NA
Return on Equity
QoQ
Q4.21
+7%
0.07
vs 0.18
Q1.22
-2%
-0.02
vs 0.07
Q2.22
-9%
-0.09
vs -0.02
Q3.22
+5%
0.05
vs -0.09
Q4.22
-7%
-0.07
vs 0.05
Q1.23
+4%
0.04
vs -0.07
Q2.23
-1%
-0.01
vs 0.04
Q3.23
+13%
0.13
vs -0.01
Institutionnal Ownership
QoQ
Q3.21
1
1
vs NA
NA
Q4.21
1
1
vs 1
NA
Q1.22
1
1
vs 1
NA
investorplace.com
9 hours ago
globenewswire.com
9 hours ago
globenewswire.com
10 hours ago
Quote Panel
Key Metrics
Forecast
NaN%2023-Revenue
-56693%2023-EPS
-1550%2023-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available